About Theranyx

About company

Theranyx is a French biotech company founded in 2010 on a unique technology platform that has proved instrumental in the development of novel therapeutic solutions for the treatment of cancer. The mission of Theranyx is to discover, develop and commercialize new antibody fragments, mainly targeting cancers, with an improved efficiency and a lower toxicity than the compounds currently available to patients.